Chinese Firms Bemoan Apple’s 30% Charge for Online Medical Consultations

Chinese Firms Bemoan Apple’s 30% Charge for Online Medical Consultations

Chinese medical firms are up in arms after smartphone giant Apple told them they must pay a 30 percent transaction fee for online consultations via mobile apps. DXY, Haodaifu and other online medical firms in China believe that the consultations...

Read more
Suzhou’s Alphamab Oncology Approved to IPO on Hong Kong Exchange

Suzhou’s Alphamab Oncology Approved to IPO on Hong Kong Exchange

Alphamab Oncology, which was spun out of Suzhou Alphamab last year, was approved to IPO in Hong Kong under the Exchange’s pre-revenue rules. The bi-specifics company has eight oncology molecules in development, four of them in clinical...

Read more
Harbour Antibodies Partners with Abveris, a Boston Drug Discovery CRO

Harbour Antibodies Partners with Abveris, a Boston Drug Discovery CRO

Harbour Antibodies, the Dutch drug discovery subsidiary of Harbour BioMed, partnered with Boston’s Abveris to offer its fully-human antibody discovery services together with Abveris’ therapeutic antibody discovery services. Under a...

Read more
Alibaba shareholders approve stock split that could boost shares ahead of reported Hong Kong IPO

Alibaba shareholders approve stock split that could boost shares ahead of reported Hong Kong IPO

Alibaba shareholders voted in favor of a one-to-eight stock split at the company’s annual general meeting. The stock split will increase the number of shares at a lower price and Alibaba said it could help with future “capital raising...

Read more
China’s Virtual Rail Transit System Gets Put Through Its Paces in Doha

China’s Virtual Rail Transit System Gets Put Through Its Paces in Doha

A virtual rail transit system started being tested in the extreme temperatures of Doha, the capital of Qatar, last week as the Chinese developer looks to bid for the 2022 Qatar World Cup transport contract. Developed by train maker CRRC, the...

Read more
BMW, NavInfo Partner on Hi-Res Maps for Self-Driving Vehicles

BMW, NavInfo Partner on Hi-Res Maps for Self-Driving Vehicles

Beijing-based NavInfo, China’s leading digital map provider, is teaming up with the China unit of Germany’s auto giant Munich-based Bayerische Motoren Werke China to provide it with high-resolution map services for its research and...

Read more
PayPal launches international money transfer service Xoom across Europe

PayPal launches international money transfer service Xoom across Europe

U.S. payments company PayPal <PYPL.O> is expanding further in Europe by launching its international money transfers service Xoom in Britain and 31 other countries across the continent. Xoom allows customers to transfer money abroad to more...

Read more
Tesla’s Shanghai Plant Hires First Staff to Start Trial Production in September

Tesla’s Shanghai Plant Hires First Staff to Start Trial Production in September

The Tesla Shanghai Gigafactory will have its first team of employees as of this month’s end after recent intensive recruitment. The plant will begin trial production in September, 21st Century Business Herald reported. Those surviving a...

Read more
I-Mab Announces IND Approval for Its Proprietary TJC4, A Potentially Differentiated CD47 Antibody, to Initiate Clinical Trials in China

I-Mab Announces IND Approval for Its Proprietary TJC4, A Potentially Differentiated CD47 Antibody, to Initiate Clinical Trials in China

I-Mab Biopharma (“I-Mab”), a clinical stage biotech company exclusively focusing on discovery and development of innovative biologics in immuno-oncology and autoimmune diseases, announces that the National Medical Products...

Read more
HitGen Approved for $97 Million IPO on Shanghai’s STAR Board

HitGen Approved for $97 Million IPO on Shanghai’s STAR Board

HitGen, a Chengdu small molecule discovery company, has been approved for a $97 million IPO on Shanghai’s new Science and Technology Innovation Board. HitGen has built a DNA-encoded library that contains nearly 400 billion novel, diverse...

Read more
Ascentage Starts China Trial of Apoptosis Cancer Drug

Ascentage Starts China Trial of Apoptosis Cancer Drug

Ascentage Pharma, a Suzhou specialist in apoptosis drugs, has started China clinical trials of its novel Bcl-2 selective inhibitor in patients with hematologic malignancies. One year ago, the company began trials of APG-2575 in the US and...

Read more
Trump declines to set U.S. uranium production quotas

Trump declines to set U.S. uranium production quotas

U.S. President Donald Trump late Friday declined to issue quotas for domestic uranium production but instead ordered a new 90-day review by a group of federal agencies. Trump said in a written memorandum he did not concur with a U.S. Commerce...

Read more
Do NOT follow this link or you will be banned from the site!